(Reuters) - Valeant Pharmaceuticals International Inc said on Friday that it would increase the cash component in its takeover bid for Botox-maker Allergan Inc for the second time this week, contingent on the two sides negotiating.
Valeant said it would pay $72 in cash - up from $58.30 on Wednesday - and 0.83 share of Valeant stock for each ALLERGAN (AGN.NY)share.
(Reporting by Rod Nickel in Winnipeg, Manitoba; Editing by Chris Reese)
